1.16
price down icon3.33%   -0.04
after-market After Hours: 1.15 -0.01 -0.86%
loading
Ekso Bionics Holdings Inc stock is traded at $1.16, with a volume of 54,922. It is down -3.33% in the last 24 hours and down -3.33% over the past month. Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
See More
Previous Close:
$1.20
Open:
$1.17
24h Volume:
54,922
Relative Volume:
0.64
Market Cap:
$24.24M
Revenue:
$18.28M
Net Income/Loss:
$-15.20M
P/E Ratio:
-0.9587
EPS:
-1.21
Net Cash Flow:
$-12.21M
1W Performance:
-4.13%
1M Performance:
-3.33%
6M Performance:
-14.71%
1Y Performance:
+58.25%
1-Day Range:
Value
$1.10
$1.19
1-Week Range:
Value
$1.10
$1.27
52-Week Range:
Value
$0.65
$3.1285

Ekso Bionics Holdings Inc Stock (EKSO) Company Profile

Name
Name
Ekso Bionics Holdings Inc
Name
Phone
510-984-1761
Name
Address
101 GLACIER POINT, SAN RAFAEL
Name
Employee
72
Name
Twitter
@EksoBionics
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
EKSO's Discussions on Twitter

Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-14-16 Initiated SunTrust Buy

Ekso Bionics Holdings Inc Stock (EKSO) Latest News

pulisher
03:15 AM

Human Augmentation Market Report 2024 Highlighting Rising - openPR

03:15 AM
pulisher
Sep 26, 2024

Speech Pathology Services Market Outlook: 2023 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews

Sep 26, 2024
pulisher
Sep 24, 2024

Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com - Defense World

Sep 24, 2024
pulisher
Sep 19, 2024

TNR, The Niche Research says :Global Wearable Robotic Exoskeleton Market is Expected to Expand at a CAGR of 44.3% (2024 to 2034). This Growth Projection Covers Segments Including Type, Application, Functionality, Technology, End User,Region - Yahoo Finance

Sep 19, 2024
pulisher
Sep 18, 2024

Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Esperion CEO Sheldon Koenig sells shares worth over $26k - Investing.com

Sep 18, 2024
pulisher
Sep 17, 2024

BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to an Underperform from a Neutral - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Stock Performance Spotlight: Esperion Therapeutics Inc. (ESPR) Ends the Day at 1.76, Down by -7.85 - The Dwinnex

Sep 17, 2024
pulisher
Sep 16, 2024

EMINOVA HOLDINGS INTERNATIONAL signed a 1.5 M USD FUND RAISING AGREEMENT for "BIOREL KIDS FUN FOAM’ product - EIN News

Sep 16, 2024
pulisher
Sep 16, 2024

National Bank of Canada FI Raises Stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

Ekso Bionics (NASDAQ:EKSO) Earns Hold Rating from Analysts at StockNews.com - Defense World

Sep 16, 2024
pulisher
Sep 11, 2024

Speech Pathology Services Market Outlook: 2022 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews

Sep 11, 2024
pulisher
Sep 09, 2024

Human Augmentation Market 2024 Growth factor – Samsung Electronics Co. Ltd.,Google LLC,Ekso Bionics Holdings Inc.,Garmin Ltd. – Cauverynews - Cauverynews

Sep 09, 2024
pulisher
Sep 08, 2024

Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com - Defense World

Sep 08, 2024
pulisher
Sep 07, 2024

Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - The Malaysian Reserve

Sep 07, 2024
pulisher
Sep 06, 2024

Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - Lelezard

Sep 06, 2024
pulisher
Sep 06, 2024

Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - Yahoo Finance

Sep 06, 2024
pulisher
Sep 03, 2024

Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow

Sep 03, 2024
pulisher
Sep 02, 2024

Ekso Bionics Holdings Inc (EKSO) Becoming More Attractive for Investors - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

Medical Exoskeleton Market Statistical Forecast, Trade - openPR

Sep 02, 2024
pulisher
Aug 31, 2024

StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World

Aug 31, 2024
pulisher
Aug 30, 2024

SEC Form 424B4 filed by Ekso Bionics Holdings Inc. - Quantisnow

Aug 30, 2024
pulisher
Aug 29, 2024

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - ForexTV.com

Aug 29, 2024
pulisher
Aug 29, 2024

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - StockTitan

Aug 29, 2024
pulisher
Aug 29, 2024

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding - Simply Wall St

Aug 29, 2024
pulisher
Aug 26, 2024

Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update - Yahoo Finance

Aug 26, 2024
pulisher
Aug 24, 2024

Lawsuit for Investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Shares Announced by Shareholders Foundation - Newswire

Aug 24, 2024
pulisher
Aug 23, 2024

Ekso Bionics (NASDAQ:EKSO) Receives New Coverage from Analysts at StockNews.com - Defense World

Aug 23, 2024
pulisher
Aug 21, 2024

Ekso Bionics Holdings Inc (EKSO) rating initates by SunTrust - Knox Daily

Aug 21, 2024
pulisher
Aug 20, 2024

Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - GlobeNewswire

Aug 20, 2024
pulisher
Aug 20, 2024

Ekso Bionics secures Medicare reimbursement for exoskeleton - Investing.com India

Aug 20, 2024
pulisher
Aug 20, 2024

Ekso Bionics secures Medicare reimbursement for exoskeleton - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - StockTitan

Aug 20, 2024
pulisher
Aug 20, 2024

Ekso Bionics Holdings (FRA:23E2) 14-Day RSI : 35.05 (As of Aug. 20, 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 20, 2024

Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - Yahoo Finance

Aug 20, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) LT-Debt-to-Total-Asset : 0.19 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Debt-to-Revenue : 0.34 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Short-Term Debt & Capital Leas - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Total Current Liabilities : $7.70 Mil (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Growth Rank : 7 (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Total Liabilities : $14.93 Mil (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

EKSO (Ekso Bionics Holdings) Long-Term Debt : $4.35 Mil (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

Ekso Bionics Holdings (LTS:0IFR) 3-Year Dividend Growth Rat - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

Ekso Bionics Holdings (STU:23E2) Future 3-5Y Total Revenue Growth Rate : 25.06 (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

Ekso Bionics Holdings (STU:23E2) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

Ekso Bionics Holdings (LTS:0IFR) 14-Day RSI : 38.39 (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

Ekso Bionics Holdings (STU:23E2) EV-to-Revenue : 0.94 (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

Ekso Bionics Holdings (LTS:0IFR) Altman Z-Score : -12.37 (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

EKSO (Ekso Bionics Holdings) Float Percentage Of Total Shar - GuruFocus.com

Aug 17, 2024
pulisher
Aug 15, 2024

EKSO (Ekso Bionics Holdings) EV-to-Revenue : 1.04 (As of Aug. 15, 2024) - GuruFocus.com

Aug 15, 2024

Ekso Bionics Holdings Inc Stock (EKSO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$25.87
price up icon 0.15%
$254.32
price down icon 0.19%
$81.46
price up icon 0.79%
medical_instruments_supplies BAX
$37.97
price down icon 2.42%
medical_instruments_supplies WST
$300.16
price down icon 3.49%
medical_instruments_supplies COO
$110.34
price up icon 0.51%
Cap:     |  Volume (24h):